Erakusten 1 - 1 emaitzak -- 1 bilaketa honetara 'for the PRESS XII study group', Bilaketaren denbora: 0,02s Findu emaitzak
  1. 1
    Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)

    Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double bli... nork Manjunath Krishnappa, Kishor Patil, Krupi Parmar, Purav Trivedi, Nirali Mody, Chintan Shah, Khushboo Faldu, Sanjay Maroo, for the PRESS XII study group, Deven Parmar

    Argitaratua 2020-06-01
    Testu osoa
    Artikulua

Bilaketa egiteko lanabesak: